SPOTLIGHT -
Transplant Eligibility in Patients With NDMM
Naresh Bumma, MD, reviews data from the final analysis of the GRIFFIN trial investigating a quadruplet induction therapy regimen in newly-diagnosed multiple myeloma and discusses how patients are evaluated for transplant.
Treatment Approaches for Patients With Newly-Diagnosed Multiple Myeloma (NDMM)
Ashley Rosko, MD, presents the case of a 57-year-old male with newly-diagnosed multiple myeloma for discussion.
